Biotech entity
All 1 tracked stories fall under one category: pharma. Bernie Sanders is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Bernie Sanders, all published on February 26, 2026.
Last mentioned: 3d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Bernie Sanders is most often covered alongside Eli Lilly, which appears in 1 of these 1 story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Bernie Sanders, all published on February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bernie Sanders. Shared-story counts are live from our verified record — not editorial picks.
Novo Nordisk has announced a significant reduction in the list prices for its leading GLP-1 medications, Ozempic and Wegovy, with cuts reaching up to 50%. This strategic move follows months of regulatory scrutiny and public pressure regarding the affordability of metabolic health treatments in the United States.
Bernie Sanders is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
